Real-World and Patient-Reported Outcomes of Dupilumab and Other Biological Drugs for Chronic Obstructive Pulmonary Disease—A Systematic Review
Background: Over the last few decades, the efficacy of biological therapies for COPD has been evaluated by different randomized controlled trials (RCTs). Still, the evaluation of real-world data and patient-reported outcome measures (PROMs) have not been performed in this field before. In the curren...
Saved in:
| Main Authors: | Ophir Freund, Ori Wand, Sara Kutzkel, Boaz Tiran, Irina Pumin, Inbal Friedman Regev, Liran Levy, Amir Bar-Shai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/14/21/2390 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Experience of Dupilumab Treatment for Patients with COPD – A Single Center Prospective Study
by: Freund O, et al.
Published: (2025-08-01) -
Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPD
by: Karl J. Staples, et al.
Published: (2025-03-01) -
Εosinophilic Chronic Obstructive Pulmonary Disease. What Do We Know So Far?
by: Konstantinos Bartziokas, et al.
Published: (2024-12-01) -
Prognostic role of blood eosinophils in acute exacerbations of chronic obstructive pulmonary disease: systematic review and meta-analysis
by: Ombretta Para, et al.
Published: (2025-03-01) -
Eosinophil count and treatment response in COPD patients
by: CR Kiran, et al.
Published: (2025-07-01)